Oxford University Press (OUP), Bioinformatics, 22(29), p. 2892-2899
DOI: 10.1093/bioinformatics/btt492
Full text: Download
Motivation: After more than a decade since microarrays were used to predict phenotype of biological samples, real-life applications for disease screening and identification of patients who would best benefit from treatment are still emerging. The interest of the scientific community in identifying best approaches to develop such prediction models was reaffirmed in a competition style international collaboration called IMPROVER Diagnostic Signature Challenge whose results we describe herein.